You tried GLP-1 medications and plateaued before reaching your goal
doi: 10.3389/fnagi.2024.1487875 Received 28 August 2024 Accepted 19 November 2024 Published 05 December 2024 Volume 16 - 2024 Edited by Enzo Emanuele, 2E Science, Italy Reviewed by Xiaoxiao Lin, University of California, Santa Barbara, United States David Toloza-Ramirez, Andres Bello University, Chile Updates Copyright 2024 Zhang, Zhang, Zhang, Tao and Zhang
10.1089/jmf.2020.4784 286
Underexplored peptide systems may struggle to compete directly with GLP-1-based therapies unless they offer clear advantages, such as improved tolerability, complementary mechanisms, or benefit in patient populations poorly served by existing drugs